Completed Research
Projects
Secondhand smoke Exposure and Smoke-free Legislation (SESL)
Project
The European Community is dedicated to the Tobacco Policy of a
Smokefree EU but its recommendations for Smokefree laws in every
(MS) will not achieve this. MS may adopt laws that do not fulfil
the aims of Tobacco Policy as set out particularly in Article 8 of
the WHO Framework Convention for Tobacco Control (FCTC). Smokefree
policies differ in MS ranging from fully comprehensive laws in
countries such as Ireland, UK, Sweden, Finland Slovenia and
Estonia, and nearly comprehensive laws in France, Latvia, Italy and
Bulgaria whereas Spain, Portugal, Greece and Denmark have laws that
can only be regarded as partial. Several countries including
Germany, Austria Luxemburg and many of the Central and Eastern EU
countries have yet to introduce strong Smokefree laws.
The ENSP 'Athens Declaration' having considered the effects of
the Smokefree legislation urged all countries that were
contemplating Smokefree laws to implement comprehensive ones.
For this Declaration to be fully evidence based it would be
imperative to show that the health benefits
in countries with partial laws were less than in countries with
comprehensive laws. The time frame for showing the presence or
absence of such health outcomes is likely to be years rather than
months and the needs of TC advocates are urgent. Recognising these
advocacy needs in building support for implementing
Tobacco Policy in the field of Smokefree and to be consistent with
the Pfizer Micro-Grant programme priority No 1 we feel the
most appropriate approach to supply the clearest and most
rapid support in driving advocacy for Smokefree and
Article 8 of the WHO FCTC is to measure theexposure
outcome from different model smokefree laws. The rationale
for this project is that in all countries where comprehensive laws
exist show definite exposure and health benefits and therefore it
sets out to measure the reduction in exposure and relate this to
the type of Smokefree law, partial or comprehensive, in place in 8
European countries.
The hypotheses is that comprehensive laws are the only laws to
deliver the full potential of reduction of exposure to second hand
smoke but this project now proposes to further explore if the
comprehensiveness of the law itself is the sole cause of the
reduction in exposure. Confounding or mediating
factors may include other tobacco control policy
initiatives but also may be related to factors that may be
political, socio-demographic, cultural or indeed climatic. They may
also be related to the health services available and the health
promotion being practiced in any country. Political factors such as
the participation of the population, civil obedience or indeed the
type of government whether this be conservative, centrist, liberal
or socialist. Other factors such as penalties and policing of the
law may be independent of the model and may or may not contribute
to the reduction in exposure. We feel that these important
factors must be included in the project although they were not in
the initial LOI. In particular the prevalence of smoking in the MS
may have a significant bearing on the reduction in exposure by
influencing compliance. The hypothesis being that if the
prevalence of smoking is very high compliance may be lower than in
a country where prevalence is low. This however may be more
important in pre ban phase influencing political thought rather
than actually adherence to the law once it is in place. We will
also be able to test this aspect of mediating factors.
It is contended that the project can have a major influence on
Tobacco Policy in countries that are considering introducing
Smokefree laws and on countries where less than comprehensive laws
exist and who recognise the need to comply with the EC regulations
and Article 8 of WHO FCTC and may therefore be considering changing
their laws. This applies in particular to Spain. However we
think it's essential that all countries have available the evidence
base on which the need for comprehensive laws can be
proposed. The contribution of this project to achieving a
Smokefree Europe could be very considerable and would meet the
needs of the European region and be entirely compatible
with Pfizer's Micro-Grant priority area on Tobacco
Policy Infrastructure/Capacity.
All Ireland Bar Study and Dublin Bar Study
On the 29th March 2004 the Irish government introduced a
comprehensive workplace smoking ban to protect the health of
workers. RIFTFS co-ordinated a number of studies to evaluate the
impact the ban had on levels of ETS, benzene and the respiratory
health of bar workers. In a sample of 42 bars staffing
levels, customer numbers and smoking rates were analyzed along with
ETS and Benzene. In 12 Dublin bars ultrafine particles levels
were measured as well as PM2.5 particles. In a study of the
respiratory health of bar workers, 81 workers were tested pre and
post ban.
The fieldwork for these projects was completed in 2005 and
preliminary reports of findings were available. In 2006 further
statistical analysis of research findings was done by Ms Mary
Dunne, RIFTFS statistician. In particular Ms Dunne explored the use
of Questionnaires, Environmental Markers and Bio-markers for
monitoring ETS exposure. Her review validated the questionnaires
and instruments used in monitoring ETS exposure in the above
studies.
The findings from these studies were very positive and have now
been published in peer reviewed journals.
Re-testing of Bar Workers
The positive results of pulmonary function tests on bar workers
showed some surprising changes which challenge the expected effects
of ETS on lung mechanics. The studies were carried out from 6 to 12
months after the ban but the time course and duration and magnitude
of the changes are unknown. For this reason two years after the ban
in late 2006 work commenced on the re-testing of bar workers. This
work continued throughout 2007. 73 workers were invited for
retesting. Full pulmonary function studies and exhaled breath
carbon monoxide (CO) is being conducted along with respiratory
symptom questionnaire.
Re- testing of the bar workers is now complete and in 2008 these
data will be analyzed. Results will be written up and will be
published and disseminated along with previous findings.
Study of ETS Exposure in Cars
Environmental tobacco smoke (ETS) is a major preventable
contributor to acute and chronic adverse health outcomes that
affect children disproportionately.
A number of international studies have been conducted examining
the levels of ETS produced while volunteers have smoked in cars.
Studies have also looked at attitudes and behaviours to
establishing smokefree cars and in the home.
TFRI have already conducted research to estimate the prevalence
of ETS exposure in cars. This was done through an examination
of traffic monitoring video footage, provided by Dublin City
Council and by direct observation.
Study of Exempted Workplaces/Psychiatric Hospitals and
Prisons
Introduction
One of the main objectives of this research is to investigate
Environmental Tobacco Smoke (ETS) exposure levels in special
hospitals (psychiatric) within the Republic of Ireland where there
is an exemption to the smoking ban.
The exposure measurements are used to quantify and address the
following questions:
- How do exposure levels in locations where a ban is in
operation, compare to hospitals and other areas which are exempted
from the ban, and
- How do these exposure levels compare with pre and post ban
levels in a selection of dwellings?
Methodology
In order to complete the objectives, the following indoor air
quality metrics were recorded and logged within each hospital for a
period of minimum 2-3 hours per 'smoking area'.
- The measurement of airborne particles (both concentration and
mass) inside designated 'smoking areas' of these hospitals
- The measurement of carbon monoxide (CO) gas levels in each
location.
- The measurement of nicotine in the air in each location using
passive samplers.
In conjunction with these measurements, the following factors
were qualitatively assessed: (a) the number of subjects present
within these 'smoking areas' and the number of subjects smoking,
(b) the structural characteristics of the 'smoking area', such as
the presence of windows or any active ventilation systems.
Study of Exempted Workplaces/Psychiatric Hospitals and
Prisons
One of the main objectives of this research is to investigate
Environmental Tobacco Smoke (ETS) exposure levels in special
hospitals (psychiatric) within the Republic of Ireland where there
is an exemption to the smoking ban.
The exposure measurements are used to quantify and address the
following questions:
- How do exposure levels in locations where a ban is in
operation, compare to hospitals and other areas which are exempted
from the ban, and
- How do these exposure levels compare with pre and post ban
levels in a selection of dwellings?
Methodology
In order to complete the objectives, the following indoor air
quality metrics were recorded and logged within each hospital for a
period of minimum 2-3 hours per 'smoking area'.
- The measurement of airborne particles (both concentration and
mass) inside designated 'smoking areas' of these hospitals
- The measurement of carbon monoxide (CO) gas levels in each
location.
- The measurement of nicotine in the air in each location using
passive samplers.
In conjunction with these measurements, the following factors
were qualitatively assessed: (a) the number of subjects present
within these 'smoking areas' and the number of subjects smoking,
(b) the structural characteristics of the 'smoking area', such as
the presence of windows or any active ventilation systems.
ISAAC Study
ISAAC, the International Study of Asthma and Allergies in
childhood, was formed in 1991 to facilitate research into asthma,
allergic rhinitis and eczema by promoting a standardised
methodology. ISAAC is a unique project which has attracted
worldwide interest and unprecedented large scale participation.
This study is a follow up on the Irish arm of an international
study carried out in 1995 - the International Study of Asthma and
Allergies in Childhood (ISAAC study).
Over 10 years on, the new follow-up study for Ireland is aiming
to find out just how much things have changed since the original
ISAAC study. The smoking part of the study is focusing on the
effects of both cigarette smoking, and passive smoking. Parental
smoking is a known cause of asthma while smoking is a known trigger
of asthma. Our previous ISAAC study showed bronchitic symptoms in
smoking children and non smoking children exposed to smoking in the
home. In this regard the survey is assessing prevalence of
smoking in 3000 schoolchildren but also secondhand smoke exposure
at home, in cars and smoking among siblings and friends. The
relationship between smoking and respiratory symptoms in general as
well as asthma is being assessed. The strength of this study
is that this is the 3rd time this survey has been
performed and this will allow us to look at the possible effect of
the workplace ban.
This study was undertaken by TFRI in collaboration with the
Asthma Society of Ireland.
Statistical Analysis of Existing Prevalence
Data
A paper was prepared by Ms Mary Dunne, statistician, which
presents studies outlining the prevalence of smoking in
Ireland. All known studies since the 1970s are presented with
the prominence given to studies undertaken in the last 15
years. Firstly, findings from a European/ International
perspective are outlined, highlighting how Ireland performs in
relation to other countries. Secondly, the results from a number of
other national prevalence studies are described and finally studies
conducted at local and regional level throughout the country are
reviewed.
It is important to bear in mind that these studies are not
homogeneous; rather they vary in terms of methodology, sample size,
types of questions asked, geographical location as well as the
specific age-groups surveyed. It is therefore difficult to make
meaningful comparison between the studies. Nonetheless, it is
useful to examine the findings of each study in the light of what
has been found in other studies conducted nationally and across
Europe.
This paper has been reviewed by the RIFTFS scientific sub
committee and a number of revisions have been recommended
Smoking and Health Inequalities
This paper prepared by Ms Dunne, presents studies outlining the
relationship between smoking and health inequalities in
Ireland. All known studies since the 1970s are presented.
Evidence suggests that mortality from tobacco related causes is
higher in Ireland than in other EU countries. Standardised death
rates from circulatory system diseases were 21% higher in Ireland
than the EU-15 average in 2001, while mortality rates from diseases
of the respiratory system were more than twice the EU-15 average.
In 2001, mortality rates in general were 16% higher in Ireland than
the EU-15 average but since diseases of the circulatory and
respiratory systems accounted for approximately half of all deaths
in Ireland in 2001 (and about 44% in the EU-15 on average) it is
clear that tobacco related illness is a problem with particular
relevance here. For women standardized death rates from
malignant neoplasms of larynx and trachea/bronchus/lung were 58%
higher in Ireland than the EU-15 average.
This paper has been reviewed by the TFRI scientific sub
committee and they suggested approaching IPHI which has a special
interest in the topic
Professor Luke Clancy met with Dr. Helen McEvoy of the IPHI and
they agreed that TFRI and IPHI have developed a collaborative
project to further this important subject.
Economic Factors Effecting Smoking
Ms Dunne prepared a paper examining Consumer Price Index (CPI)
and tax on cigarettes
This paper gives a summary of the
- rationale for tobacco taxation
- the situation regarding receipts on tobacco products according
to statistics issued by the Revenue Commissioners
- the Consumer Price Index (CPI) and its use as a benchmark for
inflation
- the European Legislation on excise duties for tobacco
This paper was reviewed by the TFRI scientific sub committee and
it was agreed that TFRI collaborate with ASH Ireland to convene a
conference on this subject where all the relevant partners could
take part. This conference was titled "Taxation health
& Tobacco" and was held in Dublin in June 2007
A study of Environmental Tobacco Smoke exposure within
exempted premises -Nursing Homes as defined in the Pubic Health
Acts 2002&2004.
In 2006 TFRI submitted a research proposal titled "A study of
Environmental Tobacco Smoke exposure within exempted premises
-Nursing Homes as defined in the Pubic Health Acts 2002 &
2004" under the MRCG/HRB joint awards scheme. The
Principal Investigator for the project is Dr Pat Goodman,
Lecturer in the Physics Department in DIT, Kevin Street, Dublin.
The application was successful and RIFTFS received
€15,089 from the HRB/MRCG scheme for Year 1 of the project.
Matching funding is being provided by TFRI.
Project Overview
When the highly successful workplace smoking ban came into force
in 2004, there were a number of areas which were exempted from the
ban. One could argue that staff working in such exempted
areas as prisons, psychiatric hospitals and nursing homes are being
unfairly treated by continuing to be exposed to ETS while going
about their daily duties. This study will examine 40 Nursing Homes
in order to determine levels of exposure to Environmental Tobacco
Smoke (E.T.S.) for both staff and occupants. This will involve
using equipment to measure particulate levels in the smoking areas
within the premises. Measurements will also be conducted in
other areas which are designated as no smoking areas. These
particulate exposure measurements will be determined by use of an
Aerocet 531 monitor (or similar device), which will monitor
continuously for two or more hours in a room where the consumption
of Tobacco products takes place. In addition benzene
concentrations will also be monitored using passive absorption
diffusion tubes. The number of people smoking, the dimensions
of each room, the presence and or use of ventilation systems will
also be recorded, together with any other sources of particulates
such as cooking etc. A questionnaire will also be used to
further determine exposure of staff to E.T.S. with regard to if
they are smokers or non-smokers, and some other details.
There will be at least two visits to each venue as part of the
exposure assessment. A qualitative and quantitative questionnaire
will be carried out on the staff and will determine exposure
outside of work and attitudes towards tobacco consumption.
The effect of the Irish workplace smoking ban on birth weight
and gestational age at birth.
In 2006 TFRI submitted a research proposal titled "The effect of
the Irish workplace smoking ban on birth weight and gestational age
at birth" under the MRCG/HRB joint awards scheme. This is a
collaborative project with TFRI and Dr Sean Daly Consultant
Obstetrician and Gynaecologist in the Coombe Hospital in Dublin.
The application was successful and TFRI received €50,000 from the
HRB/MRCG scheme for this year long project.
Project Aim
This study aims to assess the effect of the smoking ban on birth
weight, gestational age at birth and preterm/ premature birth
Project Overview
Research shows that exposure to Environmental Tobacco Smoke
(ETS) can have harmful effects on the unborn infant. There are
foetal effects to pregnant women who do not smoke but who are
exposed to ETS, for example an excess risk of 20-50% for low birth
weight (LBW) at term. Infants with LBW, defined as weighing
less than 2,500 g at birth, have a higher risk of subsequent infant
morbidity, mortality, and longer-term childhood and adult adverse
consequences. There is evidence to link prenatal ETS exposure with
low birth weight, preterm/ premature birth and intrauterine growth
retardation (IUGR). A small decrement in birth weight (e.g., 25 to
50 g) may not be clinically significant for an otherwise healthy
infant, but may put infants who are already compromised by other
health conditions or risk factors at even higher risk. All
babies born preterm are at risk for serious health problems as the
earlier a child is born, the less she will weigh, the less
developed her organs will be, and the more complications she is
likely to face.
In addition, exposure may increase the risk of spontaneous
abortion, sudden infant death syndrome, and development of
childhood cancers and cognition and behavioural problems.
The proportion of babies of low birth weight (below 2,500 grams)
increased from close to 4 per cent of all births in Ireland in 1993
to almost 5 per cent in 2002. The rate of low birth weight among
unskilled manual groups was twice that of the professional groups
in the early 1990s (see background section).
In March 2004 the workplace smoking ban was introduced in
Ireland. This made it illegal to smoke in almost all workplaces
with a few exceptions which include prisons and nursing homes. This
study aims to assess the effect of the smoking ban on birth weight,
gestational age at birth and preterm/ premature birth.
Smoking Cessation Services in Ireland - An evaluation of
services available and their effectiveness.
In 2006 TFRI submitted a research proposal titled "Smoking
Cessation Services in Ireland - An evaluation of services available
and their effectiveness". This is s two year project, the
application was successful and RIFTFS received a €30,000
Partnership award from the HRB scheme for Year one in 2006 and
€30,000 for year two in 2007.
Project Aim
The aim of this research project is to assess the range, the
availability and the effectiveness of smoking cessation services
throughout the country. RIFTFS is undertaking this work in
partnership with the Health Promoting Hospital Network, the
Institute of Public Health and the HSE.
Project Overview
Tobacco is the major preventable cause of death and chronic
disability in Ireland today and a major cause of health inequality.
Tobacco related cardiovascular and respiratory diseases and cancer
cause approximately 6,500 deaths p.a. in Ireland. Evidence suggests
that mortality from tobacco related causes is higher in Ireland
than in other EU countries (Burke et al., 2004). A recent
study found that, between 1985 and 2000, Coronary Heart Disease
(CHD) mortality rates in Ireland fell by 47% in those aged 25-84
and 25.6% of the observed decrease in mortality was attributed to
declining smoking prevalence (Bennett et al. 2006).
Smoking prevalence has been decreasing since the 1980's with the
current national rate being 24% (OTC /TNS MRBI). Rates among
women are increasing whereas among young men they are decreasing
(HBSC 2001/02). The 1998 European Community Household Panel
Survey found that young Irish women (aged 16-24) had prevalence
rates of 35% (2nd highest of the 11 countries) for those
with "low" educational attainment compared to 24% for those with
"high" educational attainment. The 2000 ECHP found that there
have actually been increases in smoking among lower income and
social class groups. Smoking among manual working class groups are
twice those of professional and managerial groups. The fact
that many studies show that smoking is more prevalent in the lower
socio-economic groups suggests that tobacco control policies should
focus specifically on these groups.
Tobacco is highly addictive and the difficulties associated with
quitting are well documented.
In the government's strategy document, "Towards a tobacco Free
Society", a key strategic objective is to significantly increase
the number of people who stop smoking each year. A key method
of achieving this target is the provision of cessation programmes
to assist smokers to quit. The Minister for Health and Children
launched the National Smoking Cessation campaign, 'Every Cigarette
is Doing You Damage' in November 2003. Smoking cessation
services are available throughout Ireland and are provided in both
community and hospital settings. Different types of services exist
and are provided by health care professionals and community
workers.
Smoking cessation interventions are effective and are extremely
cost effective (Tilson et al. 2004).
The aim of this research project is to assess the range, the
availability and the effectiveness of smoking cessation services
throughout the country.
Smoking Prevalence in the Gay and Lesbian Community.
It was decided to gather prevalence data on minority groups in
Ireland to enable better targeting of resources and services, one
of the groups identified was the Irish Gay and lesbian
Community. In consultation with a statistician a mini
questionnaire was produced covering areas such as age at which
smoking commenced, amount smoked at present, desire to quit, number
of quit attempts, aids services or medications used to aid
cessation attempts. The best circulation method available to
us was through the GCN Magazine which was conducting a general
survey of its readership both on line and in magazines purchased.
After consultation with GCN Magazine it was agreed that our
questions be included in their survey.
In 2007 the survey was completed and statistical analysis of the
findings was performed. Findings were presented at the ECToH
Conference in Basel in October 2007, which stated that in Ireland
smoking in the Gay/Lesbian community is related to income age and
S/E group as is found in the general population. There is no
evidence in this country to suggest that smoking is significantly
more common in this community when due care is taken to match for
these demographic data.
Development of a PhD studentship on the Economics of Tobacco
Control
The workplace smoking ban introduced into Ireland in March 2004
and has subsequently been shown to be an effective public health
policy measure. It is argued however to have a negative
economic impact on the hospitality industry and on the economy
overall. To examine this issue further RIFTFS undertook to fund a
PhD studentship and in December 2006 Ms Laura Maran was appointed
as a PhD student under the direction of Prof Charles Normand,
Professor of Health Policy and Management, Trinity College Dublin.
It is planned that RIFTFS will fund the studentship for a further
year to November 2008. Ms laura Maran has been awarded her PhD in
2011.
European Network of Smoking Prevention/ Media Studies
Under the ENSP Framework Project Scheme 2004 - 2005, the
Research Institute for a Tobacco Free Society (RIFTFS) undertook a
comprehensive health impact assessment of the Workplace Tobacco Ban
in Ireland. As part of this project RIFTFS collaborated with the
School of Communications in DCU and a study of the media coverage
of the Irish workplace smoking ban was conducted with the aims of
analyzing the themes and trends of the coverage generally as well
as evaluating the effectiveness of the pro-ban advocates'
communication campaign. The study provides potential lessons for
public health advocates seeking to engage in the policy process
more effectively through the news media. The findings can be
used to increase awareness of the strategies used by the
hospitality and tobacco industries to counteract any campaign for a
workplace smoking ban.
The study was completed in 2007 and results of the study showed
that the pro-ban strategy to consistently and repeatedly frame the
ban as a worker safety and public health issue proved
effective.
The anti-ban lobby almost entirely avoided health and scientific
arguments. They did succeed temporarily in diverting the focus of
the ban away from health using economic, political and legislative
arguments. In addition the anti-ban lobby used tactics similar to
those used fighting other international bans. Emphasis of
negative economic impact, erosion of cultural or national identity
and freedom of choice were arguments frequently used against the
ban.
fMRI Study to Examine Neurocognitive Processes in
Nicotine Dependence
The goal of this research is to investigate the role of specific
neurocognitive processes in nicotine dependence. The
processes in question are those involved in the control of
behaviour and have been associated with specific cortical loci
including the anterior cingulate cortex and dorsolateral prefrontal
cortex. Using functional Magnetic Resonance Imaging (fMRI), a
non-invasive technique for visualising brain function in
vivo, we will investigate:
- If neurocognitive deficits that have previously been observed
in abusers of drugs other than nicotine are present in nicotine
dependent individuals;
- If the presence or magnitude of these deficits are predictive
of relapse for those nicotine dependent individual enrolled in
smoking cessation programmes.
This research is being carried out in partnership with Dr Hugh
Garavan, Director of Functional Imaging, Institute of Neuroscience,
Trinity College Dublin and Professor Luke Clancy, Director General,
RIFTFS
The Development of an agreed national definition of a smoker
and a telephone survey instrument capable of delivering a national
estimate of smoking prevalence by sex, age and socio-economic
group.
Project Aim
To create an agreed definition of a smoker, and to develop a
telephone survey instrument capable of delivering a national
estimate of smoking prevalence by sex, age, socio-economic group
and HSE Regional area.
Project Overview
Tobacco is the major preventable cause of death and chronic
disability in Ireland today and a major cause of health inequality.
Tobacco related cardiovascular and respiratory diseases and cancer
cause approximately 6,500 deaths p.a. in Ireland. Evidence suggests
that mortality from tobacco related causes is higher in Ireland
than in other EU countries (Burke et al., 2004). A recent
study found that, between 1985 and 2000, Coronary Heart Disease
(CHD) mortality rates in Ireland fell by 47% in those aged 25-84
and 25.6% of the observed decrease in mortality was attributed to
declining smoking prevalence (Bennett et al. 2006).
Smoking prevalence has been decreasing since the 1980's at
least, but the rate is slowing since the mid-1990s, particularly
among women. Rates among young Irish women are higher than
the international average (HBSC 2001/02; ESPAD 2003). The
2000 ECHP found that there have actually been increases in smoking
among lower income and social class groups. Smoking among manual
working class groups are twice those of professional and managerial
groups.
Tracking changes in smoking prevalence over time provides
important information in aiding current primary prevention efforts
and in predicting future adult disease consequences. The EU Council
Recommendation on prevention of smoking and on initiatives to
improve tobacco control, 2002, recommends that member states
continue developing strategies and measures to reduce the
prevalence of smoking, such as general programmes to overcome
tobacco addiction. To evaluate and monitor the effectiveness
of these strategies (workplace smoking ban, taxation, cessation
strategies, labeling and packaging etc.) it is crucial that we can
accurately measure prevalence and disseminate the results
nationally and internationally.
The main national studies that have sampled the whole population
(rather than young people only) and have attempted to measure the
prevalence of smoking in Ireland (SLÁN, the OTC/ TNS mrbi survey,
the Drug Use in Ireland and Northern Ireland Drug Prevalence Survey
and the ECPH (European Community Household Panel Survey based on
the Living in Ireland Panel Survey (LII)) have found differing
results for smoking prevalence. These studies used different
methodologies and samples and asked different questions to elicit
information on smoking prevalence.
We therefore propose to create an agreed definition of a smoker,
and to develop a telephone survey instrument capable of delivering
a national estimate of smoking prevalence by sex, age,
socio-economic group and HSE Regional area. Differences in
prevalence and patterns of tobacco use in specific population
subgroups can be used to demonstrate the need for focused
interventions.
Prevalence of Smoking in Immigrants - Polish
There are 250,000 eastern European Immigrants in Ireland.
Most of these are within the 18 to 35 age group. It is also
known that the prevalence of smoking in Ireland within this age
group has increased. Research relying on large population
surveys has largely ignored the hetrogenicity in tobacco use
patterns that exists within racial and ethnic groups especially by
immigrant status. It is therefore of great importance to
identify the smoking prevalence within this group of Immigrants.
This will allow for better targeting of resources and services
PESCE
RIFTFS was collaborating partner in the PESCE project.
This project was part funded by the European Commission (60%) and
part funded by RIFTFS (40%).
General Objectives PESCE PROJECT
The general objective of the project was to
- motivate increased smoking cessation interventions of GP's in
Europe by addressing the socio-economic environment of GP's
practice
- Highlight long term health benefits and economic growth brought
about by increased smoking cessation interventions by GP's, taking
into account the effects on the health sector and the improvement
of productivity and economic conditions of citizens in
general.
- Develop evidence based policy recommendations and
implementation strategies to change the socio-economic environment
in a way to motivate greater involvement of GP's in smoking
cessation interventions
RIFTFS role initially in this project was to conduct a review of
the "grey literature" available in Ireland, appraising the factors
that hinder or promote GP's smoking cessation interventions.
It is planned that RIFTFS will also contribute to evidence based
policy recommendations and practice based implementation strategies
relating to cessation interventions by GP's. Prof Luke Clancy has
been appointed to the project advisory committee.
IMCA (Indicators for monitoring COPD and Asthma in the EU)
II
Asthma and COPD are major chronic disease that have an important
impact on quality of life of individuals suffering the disease and
also have important consequences into social and health care cost.
The information available today either to prevent risk factors or
to improve clinical management and outcomes is still very limited.
The objective of the IMCA 1 project was to develop indicators to
monitor asthma and COPD in the European Union, to describe the
prevalence of COPD related symptoms, asthma at tacks, physician
diagnosed COPD by age group, gender, socioeconomic status and
geographical area and to monitor changes over time on the
indicators proposed.
The aim of the IMCA 11 project is to extend the work on
indicators already carried out by the IMCA I project by collecting
or using already available data and producing reports/papers on all
groups of indicators recommended by the project (mortality,
prevalence, risk factors, clinical management/health services and
outcomes). It is planned that routine data on mortality and
hospital discharges will be collected to estimate the indicators
defined by the IMCA I project (for a period of ten years) for all
countries involved in the project and to analyze geographical
variations and time trends on these indicators. Data on health
care, human resources and health care utilization costs to estimate
the indicators defined by the IMCA I project will also be
collected.
Available data from completed European-wide research projects
(ECRHS and ISAAC) will be used to describe the most relevant
indicators.
Joint Research Fellowships in Cancer - HRB/NCI
RIFTFS, in collaboration with Prof Gregory Connolly, Harvard
School of Public Health,
submitted a research application under the Joint Research
Fellowships in Cancer - HRB/NCI scheme in 2005. The research
project was titled "Tobacco Control Policies, Lung Cancer
and Smoking Patterns: Ireland and Massachusetts."
In the application Dr Zubair Kabir, Post Doctoral Research
Fellow/Epidemiologist applied for a two year fellowship to study
smoking patterns and smoking related diseases in the context of the
Massachusetts Tobacco Control Programme (MTCP).
Following international peer review and interview of Dr Kabir,
this application proved successful. Funding was approved and the
project commenced in September 2006 with Dr Kabir taking up post
for the first year at the Harvard School of Public Health,
Boston. In September 2007 Dr Kabir took up post for year two
of the project in The Research Institute for a Tobacco Free
Society, Dublin. Dr Kabir is being supervised by Prof Luke
Clancy and Prof Gregory Connolly for the duration of the study. As
part of the project collaboration Prof Clancy visited Harvard in
July 2007 and Prof Connolly is planned to visit RIFTFS in 2008.
Background to Project
Tobacco use is the greatest killer worldwide. In 2025 almost 10
million tobacco-related deaths are projected worldwide. Ireland
alone reports 6,500 tobacco-related deaths annually mainly lung
cancer, coronary heart diseases and chronic lung diseases. Ireland
was the first country in the world to introduce a comprehensive
nationwide workplace smoking ban in March 2004. The state of
Massachusetts in the United States is also a global leader in
anti-smoking policies and the PI has worked closely with the
Massachusetts Department of Public Health on tobacco control since
1996. In July 2004, Massachusetts introduced the state-wide
smoke-free policies. However, in January 1993 a comprehensive
Massachusetts Tobacco Control Program (MTCP) was already in place
and since then smoking ordinances were legislated in different
towns and in cities across the state of Massachusetts. Through
serious, science-based efforts the Tobacco Control Research Program
in the Harvard School of Public Health is committed to
understanding the dangers of smoking and second hand smoke
exposure, so that "denormalization" of smoking in society can
occur. Our joint research project is in accordance with the theory
that the combination of scientific evidence with capable leadership
and strong infrastructure is the best way to empower a country's
national capacity to effectively fight the tobacco epidemic. This
collaboration is a stepping stone to moving towards the Irish
government's commitment to a Tobacco Free Society. |